Zenith Drugs Share Price Debuts Strongly: 39% Premium at ₹110 on NSE SME

Zenith Drugs shares launch on NSE SME at ₹110, soaring 39.24% above the ₹79 issue price, highlighting strong market debut for the affordable, high-quality generic medicine producer.
Zenith Drugs Share Price Debuts with 39 Percent Premium

Zenith Drugs made an impressive entrance on the NSE SME, with its shares commencing trading at ₹110 each, marking a 39.24% increase from its issue price of ₹79. Known for their focus on affordable and high-quality generic medicines, the company had set its IPO price band between ₹75 to ₹79. The IPO comprised lots of 1,600 shares, allowing investors to bid for a minimum of 1,600 shares or in multiples, leading to a strong debut on the market.

Trade Intraday, Equity and Commodity in Alice Blue and Save 33.3% Brokerage.

Zenith Drugs based in Indore is dedicated to producing affordable, high-quality generic medicines. The company, adhering to WHO-GMP standards and ISO 9001:2015, offers a variety of formulations. They focus on growth, technology, and service, aiming to be a global pharmaceutical leader. With strategic investments, the company aims for continuous improvement to meet healthcare needs. 

Zenith Drugs’ IPO aims to fund new machinery (INR 1,074.82 lakhs), upgrade existing manufacturing facilities (INR 210.59 lakhs), and bolster working capital by INR 1,200 lakhs. Remaining funds will support general corporate purposes, including strategic initiatives, partnerships, and marketing efforts.

Kick start your Trading and Investment Journey Today!
Read More News
JNK India और तीन SME ने बड़े डेब्यू के साथ वित्तीय वर्ष की शुरुआत की!

IPO की भीड़: JNK India और तीन SME ने बड़े डेब्यू के साथ वित्तीय वर्ष की शुरुआत की!

इस सप्ताह JNK इंडिया के मुख्य बोर्ड IPO और तीन SMEs के डेब्यू समेत चार IPOs होंगे, जो FY25 की उम्मीदभरी और सक्रिय शुरुआत दर्शाते हैं।

Download Alice Blue Mobile App

Enjoy Low Brokerage Demat Account In India

Save More Brokerage!!

We have Zero Brokerage on Equity, Mutual Funds & IPO